Harvard Pilgrim has developed a new medical policy for urine drug screening, which is used to monitor drug misuse or abuse during substance abuse treatment and in pain management settings.
Harvard Pilgrim covers urine drug testing in the context of pain management and substance abuse treatment when it is medically necessary. The new Urine Drug Testing Medical Policy, which is effective immediately, details the situations in which Harvard Pilgrim considers urine drug testing medically necessary, as well as the situations in which it is not medically necessary. The policy also includes a reminder that medical record documentation should include the rationale for ongoing testing and indicate how results are being used to manage the member’s treatment. For detailed information, please refer to the Urine Drug Testing Medical Policy posted on our provider website.